It is reported that urinary albumin excretion is the most powerful marker for subsequent renal events in patient with type 2 diabetes and nephropathy and that the degree of albuminuria reduction is linearly related to the subsequent renal protection [37]; thus any further reduction of albuminuria in patients with diabetes is of great importance. This evidence concerns the gene ALB and type 2 diabetes mellitus.